Keryx treatment gets faster FDA review
AP - Wed Dec 2, 3:42 pm ETKeryx Biopharmaceuticals Inc. and AEterna Zentaris Inc. said Wednesday the Food and Drug Administration granted the potential cancer treatment Perifosine a fast-track review process.
4724 Stories, most recent news story added 56 minutes ago
Keryx Biopharmaceuticals Inc. and AEterna Zentaris Inc. said Wednesday the Food and Drug Administration granted the potential cancer treatment Perifosine a fast-track review process.
When all else fails, just follow the established pathway to approval.
An Amityville pharmaceutical manufacturer has obtained final federal approval to make a generic version of an ointment that treats a form of psoriasis.
BioMarin receives FDA orphan drug status for 3,4-DAP.
ST. LOUIS, Dec. 2 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE: KVa/KVb) today announced that that it has entered into an employment agreement with Interim President and Chief Executive Officer David A. Van Vliet with a term through December 31, 2011. Mr.
Eli Lilly's Cymbalta received approval from the FDA for the maintenance treatment of generalized anxiety disorder in adults.
Dyax's shares gain on news the biotech company has won regulatory approval for its drug to treat the rare disorder hereditary angioedema.
Dec. 2 (Bloomberg) -- Shares of the following companies may have unusual moves in U.S. trading . Stock symbols are in parentheses, and prices are as of 9 a.m. in New York.
Javelin Pharmaceuticals, Inc. today announced that it has submitted its drug target for pain to the U.S. Food and Drug Administration for review. The product, Dyloject, is an IV non-steroidal anti-inflammatory drug (NSAID) target for the management of acute moderate-to-severe pain in adults.
Dec. 2 (Bloomberg) -- Shares of the following companies may have unusual moves in U.S. trading . Stock symbols are in parentheses, and prices are as of 8:10 a.m. in New York.
SOUTH BEND -- A local physician believes a recent breakthrough in ovarian cancer research could help predict which women are at a greater risk.
Among the premarket stories for Wednesday, Dec. 2, from AP Financial News: -- While the retirement of McDonald's Corp. President and Chief Operating Officer Ralph Alvarez is disappointing, the casual restaurant chain has a deep enough management team to continue to fare well after his departure, an analyst said.
Keryx Biopharmaceuticals cancer drug candidate gets faster regulatory review by FDA
An Alameda County, Calif., a jury late last month returned a $50 million verdict in a class action that sought relief for Californians who'd bought Avacor, a hair-loss remedy that was marketed as an all-natural, clinically tested product. The outcome against two defendants marked the second trial victory in the same class action for the plaintiff lawyers. The earlier trial had ended in a $40 ...
Several stocks trading near $5 were poised to move on above-average volume during Wednesday's session
Ciena Corp., RF Micro Devices, Santarus and GameStop are among companies making notable moves in the U.S. market.